Topic: Scientific Research and Experimental Development tax credit

After billions in funding, Strategic Innovation Fund failed to improve Canada’s innovation performance, experts say

Nearly $3.4 billion in federal spending through the Strategic Innovation Fund (SIF) during the last three years has failed to improve Canada’s “disastrous” innovation performance and productivity, say some innovation and policy experts. An analysis by Research Money of SIF data shows that Ontario, Quebec and foreign-based firms have received the lion’s share of SIF funding.

Canada needs a targeted industrial strategy to improve innovation performance, experts say

Canada’s continued poor performance in innovation and business productivity is due to a failure to link publicly funded research and innovation programs to an industrial strategy based on the country’s strengths, say innovation experts. Meanwhile, studies by University of Toronto researchers show the federal innovation agenda has negatively impacted funding for basic, investigator-driven research but hasn’t addressed the underlying problem of industrial innovation in Canada.

The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more

Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…